Evidence map›Paper›PMID 16907926›Full record

ArticleClinical and experimental immunology2006

A potential role for interleukin-18 in inhibition of the development of Cryptosporidium parvum.

V McDonald, R C G Pollok, W Dhaliwal, S Naik, M J G Farthing, M Bajaj-Elliott

Open access · greenAbstract read
In one paragraph

Article in Clinical and experimental immunology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.4field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 48 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Review
  5. Early immune and host cell responses toFrontiers in parasitology · 2023
    Article
  6. Article
  7. PersistentMicroorganisms · 2021
    Article
  8. Review
  9. The Mucosal Innate Immune Response toFrontiers in cellular and infection microbiology · 2021
    Review
  10. Changes in the Microbiome ofMicroorganisms · 2020
    Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Systemic and Mucosal Immune Responses toCurrent tropical medicine reports · 2015
    Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Cryptosporidiosis-an overview.Journal of biomedical research · 2012
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

V McDonaldBarts and the London School of Medicine and Dentistry, Institute of Cell and Molecular Science, Centre for Gastroenterology, London, UK.
R C G Pollok
W Dhaliwal
S Naik
M J G Farthing
M Bajaj-Elliott
Queen Mary University of London · GBSt George's Hospital · GBSt George's, University of London · GB

Funding

Wellcome Trust
6 · The paper itself

Abstract

Accumulating evidence suggests that intestinal epithelial cells (IECs) constitutively express the immunoregulatory cytokine interleukin (IL)-18. IECs also serve as the host cell for the intracellular parasitic protozoan Cryptosporidium parvum. In the present study, C. parvum infection of a human enterocyte cell-line HCT-8 resulted in increased expression of IL-18 mRNA as measured by quantitative reverse transcription-polymerase chain reaction (RT-PCR). IL-18 protein was detected in control uninfected cells and following infection there was increased expression as measured by enzyme-linked immunosorbent assay (ELISA). Gene expression revealed the presence of the IL-18 receptor subunits not only in cell-lines but also in freshly isolated IECs, suggesting that IL-18-mediated signalling events may contribute to epithelial host defence during infection. Recombinant IL-18 inhibited intracellular development of the parasite in HCT-8 and HT-29 cells. Increased expression of bactericidal antibiotic peptides LL-37 and alpha-defensin 2 by IL-18 in HCT-8 and HT-29 cells may represent one mode of action by which this pluripotent cytokine aids in limiting the development of intracellular pathogens such as C. parvum in the gastrointestinal tract.

Indexed as

alpha-DefensinsAnimalsAnti-Bacterial AgentsAntimicrobial Cationic PeptidesCase-Control StudiesCathelicidinsCell LineCryptosporidiosisCryptosporidium parvumEnterocytesHT29 CellsHumansInterleukin-18Interleukin-18 Receptor alpha SubunitReceptors, InterleukinReceptors, Interleukin-18alpha-DefensinsAnti-Bacterial AgentsAntimicrobial Cationic PeptidesCathelicidinsIL18R1 protein, humanInterleukin-18Interleukin-18 Receptor alpha SubunitReceptors, InterleukinReceptors, Interleukin-18Recombinant ProteinsRNA, Messenger

Identifiers

PMID16907926
PMCPMC1809716
OpenAlexW2080840982

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.